| Dr Joe P Lester, DO | |
|
1000 Medical Center Blvd, Lawrenceville, GA 30046-0000 | |
| (770) 277-3056 | |
| (855) 204-5244 |
| Full Name | Dr Joe P Lester |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology |
| Experience | 22 Years |
| Location | 1000 Medical Center Blvd, Lawrenceville, Georgia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1326075805 | NPI | - | NPPES |
| 294313097A | Medicaid | GA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | DO1636 (Tennessee) | Secondary |
| 207L00000X | Anesthesiology | 059546 (Georgia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Northside Hospital Gwinnett | Lawrenceville, GA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| North Atlanta Anesthesia Professionals, Llc | 5496134348 | 432 |
News Archive
A study led by researchers at the Salk Institute for Biological Studies, has catapulted the field of regenerative medicine significantly forward, proving in principle that a human genetic disease can be cured using a combination of gene therapy and induced pluripotent stem (iPS) cell technology. The study, published in the May 31, 2009 early online edition of Nature, is a major milestone on the path from the laboratory to the clinic.
Researchers from the Department of Biomedical Engineering at Stony Brook University have developed a high-resolution, 3D optical Doppler imaging tomography technique that captures the effects of cocaine restricting the blood supply in vessels - including small capillaries - of the brain.
Everybody knows that if you're physically fit, you're less likely to get a wide range of diseases. What most people don't know is that some people are "naturally" in better shape than others, and this variation in conditioning makes it difficult to test for disease risk and drug effectiveness in animal models.
DiaGenic has significantly altered its business strategy during 2010 to leverage more effectively its commercial potential, and strengths in Intellectual Property (IP). The Company has made significant progress in its business activities towards big pharma since implementation of the new strategy. DiaGenic is well positioned as a multimodal partner with large pharma and imaging companies.
Emdeon Inc., a leading provider of healthcare revenue and payment cycle management solutions, today announced the signing of a definitive agreement to acquire Healthcare Technology Management Services, a management consulting company focused primarily on the healthcare payer market.
› Verified 8 days ago
| Entity Name | American Anesthesiology Associates Of Georgia Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1528068673 PECOS PAC ID: 7618934779 Enrollment ID: O20041210000442 |
News Archive
A study led by researchers at the Salk Institute for Biological Studies, has catapulted the field of regenerative medicine significantly forward, proving in principle that a human genetic disease can be cured using a combination of gene therapy and induced pluripotent stem (iPS) cell technology. The study, published in the May 31, 2009 early online edition of Nature, is a major milestone on the path from the laboratory to the clinic.
Researchers from the Department of Biomedical Engineering at Stony Brook University have developed a high-resolution, 3D optical Doppler imaging tomography technique that captures the effects of cocaine restricting the blood supply in vessels - including small capillaries - of the brain.
Everybody knows that if you're physically fit, you're less likely to get a wide range of diseases. What most people don't know is that some people are "naturally" in better shape than others, and this variation in conditioning makes it difficult to test for disease risk and drug effectiveness in animal models.
DiaGenic has significantly altered its business strategy during 2010 to leverage more effectively its commercial potential, and strengths in Intellectual Property (IP). The Company has made significant progress in its business activities towards big pharma since implementation of the new strategy. DiaGenic is well positioned as a multimodal partner with large pharma and imaging companies.
Emdeon Inc., a leading provider of healthcare revenue and payment cycle management solutions, today announced the signing of a definitive agreement to acquire Healthcare Technology Management Services, a management consulting company focused primarily on the healthcare payer market.
› Verified 8 days ago
| Entity Name | North Atlanta Professional Services Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1316959869 PECOS PAC ID: 0840291944 Enrollment ID: O20070116000197 |
News Archive
A study led by researchers at the Salk Institute for Biological Studies, has catapulted the field of regenerative medicine significantly forward, proving in principle that a human genetic disease can be cured using a combination of gene therapy and induced pluripotent stem (iPS) cell technology. The study, published in the May 31, 2009 early online edition of Nature, is a major milestone on the path from the laboratory to the clinic.
Researchers from the Department of Biomedical Engineering at Stony Brook University have developed a high-resolution, 3D optical Doppler imaging tomography technique that captures the effects of cocaine restricting the blood supply in vessels - including small capillaries - of the brain.
Everybody knows that if you're physically fit, you're less likely to get a wide range of diseases. What most people don't know is that some people are "naturally" in better shape than others, and this variation in conditioning makes it difficult to test for disease risk and drug effectiveness in animal models.
DiaGenic has significantly altered its business strategy during 2010 to leverage more effectively its commercial potential, and strengths in Intellectual Property (IP). The Company has made significant progress in its business activities towards big pharma since implementation of the new strategy. DiaGenic is well positioned as a multimodal partner with large pharma and imaging companies.
Emdeon Inc., a leading provider of healthcare revenue and payment cycle management solutions, today announced the signing of a definitive agreement to acquire Healthcare Technology Management Services, a management consulting company focused primarily on the healthcare payer market.
› Verified 8 days ago
| Entity Name | North Atlanta Anesthesia Professionals, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1982349296 PECOS PAC ID: 5496134348 Enrollment ID: O20220623000371 |
News Archive
A study led by researchers at the Salk Institute for Biological Studies, has catapulted the field of regenerative medicine significantly forward, proving in principle that a human genetic disease can be cured using a combination of gene therapy and induced pluripotent stem (iPS) cell technology. The study, published in the May 31, 2009 early online edition of Nature, is a major milestone on the path from the laboratory to the clinic.
Researchers from the Department of Biomedical Engineering at Stony Brook University have developed a high-resolution, 3D optical Doppler imaging tomography technique that captures the effects of cocaine restricting the blood supply in vessels - including small capillaries - of the brain.
Everybody knows that if you're physically fit, you're less likely to get a wide range of diseases. What most people don't know is that some people are "naturally" in better shape than others, and this variation in conditioning makes it difficult to test for disease risk and drug effectiveness in animal models.
DiaGenic has significantly altered its business strategy during 2010 to leverage more effectively its commercial potential, and strengths in Intellectual Property (IP). The Company has made significant progress in its business activities towards big pharma since implementation of the new strategy. DiaGenic is well positioned as a multimodal partner with large pharma and imaging companies.
Emdeon Inc., a leading provider of healthcare revenue and payment cycle management solutions, today announced the signing of a definitive agreement to acquire Healthcare Technology Management Services, a management consulting company focused primarily on the healthcare payer market.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Joe P Lester, DO Po Box 551420, Fort Lauderdale, FL 33355-1420 Ph: (800) 243-3839 | Dr Joe P Lester, DO 1000 Medical Center Blvd, Lawrenceville, GA 30046-0000 Ph: (770) 277-3056 |
News Archive
A study led by researchers at the Salk Institute for Biological Studies, has catapulted the field of regenerative medicine significantly forward, proving in principle that a human genetic disease can be cured using a combination of gene therapy and induced pluripotent stem (iPS) cell technology. The study, published in the May 31, 2009 early online edition of Nature, is a major milestone on the path from the laboratory to the clinic.
Researchers from the Department of Biomedical Engineering at Stony Brook University have developed a high-resolution, 3D optical Doppler imaging tomography technique that captures the effects of cocaine restricting the blood supply in vessels - including small capillaries - of the brain.
Everybody knows that if you're physically fit, you're less likely to get a wide range of diseases. What most people don't know is that some people are "naturally" in better shape than others, and this variation in conditioning makes it difficult to test for disease risk and drug effectiveness in animal models.
DiaGenic has significantly altered its business strategy during 2010 to leverage more effectively its commercial potential, and strengths in Intellectual Property (IP). The Company has made significant progress in its business activities towards big pharma since implementation of the new strategy. DiaGenic is well positioned as a multimodal partner with large pharma and imaging companies.
Emdeon Inc., a leading provider of healthcare revenue and payment cycle management solutions, today announced the signing of a definitive agreement to acquire Healthcare Technology Management Services, a management consulting company focused primarily on the healthcare payer market.
› Verified 8 days ago
Dr. Robert E Black Iii, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1000 Medical Center Blvd, Lawrenceville, GA 30046 Phone: 770-277-3056 Fax: 855-204-5244 | |
Dr. Craig M Spector, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1000 Medical Center Blvd, Lawrenceville, GA 30045 Phone: 770-963-9905 | |
Dr. Tao Hong, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1000 Medical Center Blvd, Lawrenceville, GA 30046 Phone: 678-312-1000 | |
Dr. Nazanin Jafarian, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1000 Medical Center Blvd, Lawrenceville, GA 30046 Phone: 770-277-3056 Fax: 855-204-5244 | |
Dr. Jeffrey N Gladstein, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1000 Medical Center Blvd, Lawrenceville, GA 30046 Phone: 770-277-3056 Fax: 855-204-5244 | |
Dr. Eric Benjamin Brown, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1000 Medical Center Blvd, Lawrenceville, GA 30046 Phone: 713-822-2421 | |
Luong Thi Nguyen, MD Anesthesiology Medicare: May Accept Medicare Assignments Practice Location: 1000 Medical Center Blvd, Lawrenceville, GA 30046 Phone: 678-312-1000 Fax: 678-312-3282 |